Sub-chronic low dose γ-vinyl GABA (vigabatrin) inhibits cocaine-induced increases in nucleus accumbens dopamine

Psychopharmacology

Volumn 168, Issue 3, 2003, Pages 339-343

  Schiffer, Wynne K ^a,b   Marsteller, Douglas ^a   Dewey, Stephen L ^b,c  

^a Stony Brook University   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; GABA; Microdialysis; Pharmacotherapy; Vigabatrin

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRIC ACID; COCAINE; DOPAMINE; VIGABATRIN;

ADDICTION; ANIMAL EXPERIMENT; ARTICLE; BRAIN; COCAINE DEPENDENCE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG EFFECT; ENZYME INHIBITION; LOW DRUG DOSE; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; VISUAL FIELD DEFECT;

4-AMINOBUTYRATE TRANSAMINASE; ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VIGABATRIN;

EID: 0041665143     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1446-6     Document Type: Article

References (36)

1. Ben-Menachem E, Persson LI, Schechter PJ, Haegele KD, Huebert N, Hardenberg J, Dahlgren L, Mumford JP (1989) The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients. Br J Clin Pharmacol 27:79S-85S
2. Bialer M, Johannessen S, Kupferberg HJ, Levy RH (2001) Progress report on new antiepileptic drugs. Epilepsy Res 43:11-58
3. Bolton JB, Rimmer E, Williams J, Richens A (1989) The effect of vigabatrin on brain and platelet GABA-transaminase activities. Br J Clin Pharmacol 27:35S-42S
4. Dam M (1989) Long-term evaluation of vigabatrin (γ vinyl GABA) in epilepsy. Epilepsia 30 S3:26-30
5. Dewey SL, Morgan AE, Ashby CR Jr, Kushner SA, Logan J, Volkow ND, Fowler JS, Gardner EL, Brodie JD (1998) A novel strategy for the treatment of cocaine addiction. Synapse 30:119-129
6. Dewey SL, Brodie JD, Gerasimov M, Horan B, Gardner EL, Ashby CRJ (1999) A pharmacologic strategy for the treatment of nicotine addiction. Synapse 31:76-86
7. Eke T, Talbot JF, Lawden MC (1998) Severe persistent visual field constriction associated with vigabtrin. BMJ 314:180-181
8. Gerasimov MR, Ashby CR, Gardner EL, Dewey SL (1999) γ-Vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine. Synapse 34:11-19
9. Gerasimov MR, Schiffer WK, Brodie JD, Lennon IC, Taylor SJC, Dewey SL (2000) GABA mimetic drugs differentially inhibit the dopaminergic response to cocaine. Eur J Pharmacol 395:129-135
10. Giordano L, Valseriati D, Morescalchi F, Gandolfo E (2000) Another case of reversibility of visual-field defect induced by GVG monotherapy: is young age a favorable factor? Neurol Sci 21:185-186
11. Green LB, Nelson VS (1999) Death after acute withdrawal of intrathecal baclofen: case report and literature review. Arch Phys Med Rehabil 80:1600-1604
12. Jackson MF, Esplin B, Capek R (2000) Reversal of the activity-dependent suppression of GABA-mediated inhibition in hippocampal slices from γ-vinyl GABA-pretreated rats. Neuropharmacology 39:65-74
13. Krakow K, Polizzi G, Riordan_Eva P, Holder G, MacLeod WN, Fish DR (2000) Recovery of visual field constriction following discontinuation of vigabatrin. Seizure 9:287-290
14. Kushner SA, Dewey SL, Kornetsky C (1999) The irreversible GABA transaminase inhibitor γ-vinyl-GABA blocks cocaine self-administration in rats. J Pharmacol Exp Ther 290:797-802
15. Lorini G, Fazio L, Fusari A, Cocchi R (1982) Suppression of the opiate withdrawal syndrome with GABA analogs, low-dose psychotropic drugs and acupuncture. Minerva Med 73:707-710
16. Loscher W, Frey HH (1987) One to three day dose intervals during subchronic treatment of epileptic gerbils with λ-vinyl GABA: anticonvulsant efficacy and alterations in regional brain GABA levels. Eur J Pharmacol 143:335-342
17. Malmgren K, Ben-Menachem E, Frisén L (2001) Vigabatrin visual toxicity. Epilepsia 42:609-615
18. Manuchehri K, Goodman S, Siviter L, Nightingale S (2000) A controlled study of vigabatrin and visual abnormalities. Br J Ophthalmol 84:499-505
19. Munzar P, Kutkat SW, Miller CR, Goldberg SR (2000) Failure of baclofen to modulate discriminative-stimulus effects of cocaine or methamphetamine in rats. Eur J Pharmacol 408:169-174
20. Nicolson A, Leach JP, Chadwick DW, Smith DF (2002) The legacy of vigabatrin in a regional epilepsy clinic. J Neurol Neurosurg Psychiatry 74:327-329
21. Nousiainen I, Mantyjarvi M, Kalviainen R (2001) No reversion in vigabatrin-associated visual field defects. Neurology 57:1916-1917
22. Paul SR, Kraus GL, Miller NR, Medura MT, Miller TA, Johnson MA (2001) Visual function is stable in patients who continue long-term vigabatrin therapy. Epilepsia 42:525-530
23. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, San Diego
24. Schechter PJ, Tranier Y, Jung MJ, Bohlen P (1977) Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of γ-acetylenic GABA and γ-vinyl GABA, two irreversible GABA-T inhibitors. Eur J Pharmacol 45:319-328
25. Schmitz B, Schmidt T, Jokiel B, Pfeiffer S, Tiel-Wilck K, Ruther K (2002) Visual field constriction in epilepsy patients treated with vigabatrin and other antiepileptic drugs. J Neurol 249:469-475
26. Steinhoff BJ, Freudenthaler N, Paulus W (1997) The influence of established and new antiepileptic drugs on visual perception. 1. A placebo-controlled, double-blind, single-dose study in healthy volunteers. Epilepsy Res 29:35-47
27. Stromberg MF, Mackler SA, Volpicelli JR, O'Brien CP, Dewey SL (2001) The effect of γ-vinyl-GABA on the consumption of concurrently available oral cocaine and ethanol. Pharmacol Biochem Behav 68:291-299
28. Stuppaeck CH, Deisenhammer EA, Kurz M, Whitworth AB, Hinterhuber H (1996) The irreversible γ-aminobutyrate transaminase inhibitor vigabatrin in the treatment of the alcohol withdrawal syndrome. Alcohol Alcohol 31:109-111
29. Takada K, Yanagita T (1997) Drug dependence study on vigabatrin in rhesus monkeys and rats. Arzneimittelforschung 47:1087-1092
30. Tiel-Wilck K, Jokiel B, Zinser P (1995) Afferent visual function after single dose application of gamma-vinyl GABA. Neuroophthalmology 15:305-310
31. Toggweiler S, Wieser HG (2001) Concentric visual field restriction under vigabatrin therapy: extent depends on the duration of drug intake. Seizure 10:420-423
32. Valdizan EM, Armijo JA (1992) Effects of single and multiple increasing doses of vigabatrin on brain GABA metabolism and correlation with vigabatrin plasma concentration. Biochem Pharmacol 43:2143-2150
33. 2 receptors. J Pharmacol Exp Ther 291:409-415
34. Wilton LV, Stephens MD, Mann RD (1999) Visual field defect associated with vigabatrin: observational cohort study. BMJ 319:1165-1166
35. Wu Y, Wang W, Richerson GB (2001) GABA transaminase inhibition induces spontaneous and enhances depolarization-evoked GABA efflux via reversal of the GABA transporter. J Neurosci 21:2630-2639
36. Xi ZX, Stein EA (2000) Increased mesolimbic GABA concentration blocks heroin self-administration in the rat. J Pharmacol Exp Ther 294:613-619